Nasal drug delivery--possibilities, problems and solutions.

By L. Illum. Journal of Controlled Release, 2003

1,040 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery (2017, background): “As another example, the bioavailability of leuprolide, used in the treatment of prostate cancer and hormone-dependent diseases, was found to be increased when formulated as thiolated-chitosan NPs [57].”
Intranasal drug delivery: how, why and what for? (2009, background): “Examples of nasal formulations commercially available after prescription (4, 6, 13, 39).”
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues (2008, neutral): “20 5 [79,214,215]”
Evaluation of intranasal delivery route of drug administration for brain targeting. (2018, neutral): “The nose-to-brain route via olfactory and respiratory epithelium may involve paracellular, transcellular and neuronal transport (Illum, 2003, 2000).”